Chen 2011.
Methods | RCT, 60 participants were randomly divided into 2 groups, with 30 participants in each group Participants in Group I were treated with 2 g propacetamol 15 min before the end of operation |
|
Participants | Type of surgery: lumbar spine surgery Propacetamol group Entered/completing: 30 Age (mean, SD): 48, 13 Sex (male, %): 13, 43% Control group Entered/completing: 30 Age (mean, SD): 53, 14 Sex (male, %): 14, 47% |
|
Interventions | 2 g propacetamol in 100 ml saline, intravenous injection, 15 min before the end of operation Placebo: 100 ml saline, intravenous injection, 15 min before the end of operation |
|
Outcomes | The authors did not point out which were primary outcomes Vomiting frequency in 48 h after the operation VAS pain score (0 to 10), Ramsay sedation score(0, 1, 2, 3), breathing frequency, heart rate and mean arterial pressure were observed at the time of 0 min, 30 min, 1 h, 2 h, 4 h, 6 h, 12 h, 24 h, 36 h, 48 h after the operation |
|
Source of funding | Not reported | |
Were treatment groups comparable at baseline? | Yes: sex, age, weight, height | |
Details of preoperative pain | Not reported | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No details reported |
Allocation concealment (selection bias) | Unclear risk | Not mentioned |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Not mentioned |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Reported as no incomplete outcome data in the study |
Selective reporting (reporting bias) | High risk | There were only comparisons of VAS pain scores and Ramsay sedation scores between the 2 groups as shown in Table 2 and 3 |
Size | High risk | Fewer than 50 participants per arm of the study (30 propacetamol, 30 placebo) |